BMY vs RCON · P/E 17, rev $24.46B vs rev $9.3M
Bristol-Myers Squibb Company (BMY) versus Recon Technology Ltd (RCON) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Recon Technology Ltd (RCON) is a oil & gas equipment & services company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported RCON revenue for 2025-06-30 was $9.3M. Net income was -$5.9M. Revenue was down 2.3% from 2024-06-30 to 2025-06-30. RCON currently screens at market cap $45.4M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. RCON currently screens at market cap $45.4M.
Not investment advice. Open the BMY and RCON stock pages for the full models.
Not investment advice.